The clinical significance of circulating tumor cell in metastatic Non-Small Cell Lung Cancer
Not Applicable
- Conditions
- metastatic non-small cell lung cancer
- Registration Number
- JPRN-UMIN000001896
- Lead Sponsor
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1) chemotherapy including amurubicin 2) Uncontrolled pleural effusion 3) symptomatic brain metastases 4) active concomitant malignancy 5) serious concurrent illness, such as hypertension, angina pectoris, myocardial infarction, or severe infection 6) pregnant/lactating women 7) history of severe drug allergy 8) psychiatric disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To clarify the relation between CTC and tumor response.
- Secondary Outcome Measures
Name Time Method To clarify the relation between CTC and progression-free survival or overall survival.